APP Cancer Research Summit 2025

September 25 - 27

Four Seasons Hotel Las Vegas

The First Annual APP Cancer Research Summit is Coming to Las Vegas Sept. 25 - 27!

An Oncology Research Conference for Advanced Practice Providers in Oncology

The APP Cancer Research Summit (ACRS) is a two-day conference designed to empower advanced practice providers (APPs) with the knowledge and skills needed to excel in oncology-focused clinical research. ACRS will address various topics, including the basics of clinical trial design, toxicity grading, management, and documentation, the latest trends in cancer research, and more. This conference is planned and developed with clinical research APPs to ensure we provide the education and training APPs need and want. Held in conjunction with the Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer), ACRS welcomes seasoned clinical research APPs and those interested in cancer research. Our goal is to provide a forum for APPs interested or practicing in cancer research to learn, network, and collaborate.

Advanced Registration - Allied Health (NP, PA, RN, PharmD, Fellows, Residents, Retired)

$ 275
  • Through Aug 26

General Registration - Allied Health (NP, PA, RN, PharmD, Fellows, Residents, Retired)

$ 375
  • Through Sep 27
REGISTER TODAY

Physicians Should Register for the Concurrent STOP Cancer Conference

Download a Conference Flyer!

Students, Fellows, and Industry Employees, see pricing below.  Register early to guarantee your spot!

Students - Fellows (Free Admission)

Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession. If you would like to attend as a Student, please contact info@horizoncme.com for further information.

Industry Employee - $790 Advanced - $890 General Registration

Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).

Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.

All Times Listed are for the Pacific Standard Time Zone

Thursday, September 25, 2025

11:00amPre-Conference Activity
5:00pmPre-Conference Registration Opens
6:00pmIndustry Sponsored Dinner

Friday, September 26, 2025

7:00am Check-in and Breakfast in Exhibit Hall
8:00amHorizon CME App Overview and CE Housekeeping
8:10amWelcome, Introductions, & CE Housekeeping
8:15am(01) The Daniel D. Von Hoff Keynote Lecture: Protacs – include protein degrader products – molecular glues – multiple sessions – Prostate – hormonal and targeted agents also Breast as well 
» TBA
9:15amBreak | Refreshments in Exhibit Hall
 Block One: Clinical Trials 101
9:40am(02) Clinical Trials Basics
» TBA
10:05am(03) Clinical Trial Designs
» Erin Pierce
10:30am(04) How to Be a Good Investigator
» TBA
10:50am(05) Q+A Panel and Discussion:  Block Three
» Faculty from Sessions 02-04
11:00am Gather for Lunch
11:10amLunch
11:55amDessert – Refreshments in Exhibit Hall
 Block Two: Targeted Drug Development and Biomarker Testing
12:10pm(06) Drug Development Process for Targeted Agents
» TBA
12:35pm(07) Biomarkers in Solid Tumors
» TBA
1:00pm(08) Biomarkers in Hematologic Malignancies
» Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN – Nurse Practitioner Department of Hematology and Medical Oncology  Cleveland Clinic
1:25pm(09) Q+A Panel and Discussion:  Block Three
» Faculty from Sessions 06-08
1:40pmMessage from the Cancer Charities
1:55pmBreak – Trivia for Charity in the Exhibit Hall
 Block Three: The Evolving Role of Advanced Practice Providers in Clinical Trials
2:15pm(10) From Being a Sub-investigator to Clinical Trial Leadership
» TBA
2:40pm(11) Involvement in Clinical Trial Protocol Development/Writing/Review and Obtaining Funding
» TBA
3:05pm(12) Working with a Biostatistician When Developing Your Own Investigator-Initiated Trial
» TBA
3:30pm(13) Getting a Trial Through Startup/Operationalizing a Trial
» TBA
 Block Four: The Evolving Role of Advanced Practice Providers in Clinical Trials (Continued)
3:55pm(14) How to Interpret Research Data and Develop a Conference Presentation/Publication
» TBA
4:20pm(15) Q+A Panel and Discussion:  Block Two
» Faculty from Sessions 10-14
5:15pmNetworking Reception – Exhibit Hall

Saturday, September 27, 2025

7:00amCheck-in
7:10amBreakfast Symposium- sponsored by ​​​​​TBA
» TBA
7:55amHorizon CME App Overview and CE Housekeeping
8:00amWelcome and Introductions
 Block Five: Adverse Event Management in the Setting of a Clinical Trial
8:10am(16) AEs with Targeted Agents
» TBA
8:40am(17)  AEs with Immune Checkpoint Inhibitors
» Diane Barber, PhD, ANP-BC, AOCNP, FAANP, FAAN – Manager of Advanced Practice Providers Department of Investigational Cancer Therapeutics MD Anderson
9:10am(18) AE Grading & Documentation
» Madeline Merrill, AGNP-BC, MSN – Clinical Trials Nurse Practitioner Memorial Sloan Kettering Cancer Center
9:40am(19) Q+A Panel and Discussion: Block Five
» Faculty from Sessions 16-18
9:50amBreak – Refreshments in the Exhibit Hall
10:20amPoster Session
 Block Six: Clinical Trial Methodology
10:55am(20) Strategies for Patient Recruitment
» TBA
11:15am(21) Novel Endpoints for Therapeutic Response in Early Phase Trials
» TBA
11:35am(22) The Evolution of Agnostic Drug Approval: Where Are We Now? 
» TBA
11:55am(23) Role of Patient Advocacy in Early Phase Trials
» TBA
12:15pm(24) Q+A Panel and Discussion:  Block Six
» Faculty from Sessions 20-23
12:35pmGather for Lunch
12:45pm Buffet Lunch & Non-CME/CE Presentation Sponsored by TBA
» TBA
1:30pmDessert Break in Exhibit Hall
 Block Seven: Advances With Bispecific Therapy and CAR-T Therapy in Cancer Care
1:45pm(25) Recent Updates in MM
» Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN – Nurse Practitioner Department of Hematology and Medical Oncology  Cleveland Clinic
2:10pm(26) Advances in Bispecific Therapy and CAR-T Therapy in Hematologic Malignancies
» TBA
2:35pm(27) Advances in Bispecific Therapy and CAR-T Therapy in Solid Tumors
» TBA
3:00pmBreak – Refreshments in the Exhibit Hall
3:20pm(28) AEs with Bispecific Therapy and CAR-T Therapy in Hematologic Malignancies and Solid Tumors
» TBA
3:45pm(29) Community Coordination of Care in Bispecifics
» TBA
4:10pm(30) Q+A Panel and Discussion: Block Seven
» Faculty from Sessions 25-29
4:30pmClosing Comments

2025 Conference Planning Committee

Diane Barber, PhD, ANP-BC, AOCNP, FAANP, FAAN

Manager of Advanced Practice Providers Department of Investigational Cancer Therapeutics MD Anderson

Madeline Merrill, AGNP-BC, MSN

Clinical Trials Nurse Practitioner Memorial Sloan Kettering Cancer Center

Erin Pierce, MSN, APRN, FNP-C

Associate Clinical Investigator Nurse Practitioner HonorHealth Research Institute

Kelsey P. Martin, AG-ACNP-BC, AOCNP

Nurse Practitioner
Sarah Cannon Research Institute

Christa Braun-Inglis, DNP, APRN-Rx, FNP-BC, AOCNP

Nurse Practitioner/Assistant Researcher/CCDR Lead University of Hawaii Cancer Center/Hawaii M/U NCORP Clinical Faculty, UH Nancy Atmospera-Walch School of Nursing

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN

Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic Cleveland, OH

Accommodations

We want to ensure that your time at the APP Cancer Research Summit (ACRS) 2025 conference is convenient and memorable. Staying at our host hotel provides a hassle-free experience and puts you at the heart of the activity surrounding the conference.

Overnight Accommodations:

Booking Deadline: TBA

Click here to book your room today!

Room rate: TBA

Parking: $45 Overnight Parking, Daily $25

Disclaimer:
All reservations must be booked using the link above before the closing date listed. Overnight accommodation, parking, and resort fees will revert back to standard hotel pricing outside of the dates above. A set number of rooms have been blocked off for the discounted pricing. If all of those rooms have already been booked, discounted pricing may not be available for additional rooms or accommodations.